**Core Concept**
Acarbose is an alpha-glucosidase inhibitor that works by delaying carbohydrate absorption in the small intestine. This class of drugs specifically targets enzymes responsible for breaking down complex carbohydrates into easily absorbable monosaccharides.

**Why the Correct Answer is Right**
Acarbose acts by inhibiting intestinal alpha-glucosidases, including sucrase, maltase, and isomaltase. This inhibition prevents the breakdown of complex carbohydrates, such as starches and disaccharides, into their simpler forms. As a result, the absorption of glucose is delayed, leading to lower postprandial glucose levels. This mechanism makes acarbose an ideal choice for managing postprandial hyperglycemia in patients with diabetes.

**Why Each Wrong Option is Incorrect**
**Option B:** Glipizide is a sulfonylurea that stimulates insulin release from pancreatic beta cells. It does not have a direct effect on carbohydrate absorption and therefore is not used to delay carbohydrate absorption.
**Option C:** Metformin is a biguanide that decreases hepatic glucose production and increases insulin sensitivity. While it is effective in managing blood glucose levels, it does not affect carbohydrate absorption.
**Option D:** Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that enhances glucose-dependent insulin secretion and suppresses glucagon release. It does not affect carbohydrate absorption and is used to improve glycemic control.

**Clinical Pearl / High-Yield Fact**
Acarbose is often used in combination with other antidiabetic agents to manage postprandial hyperglycemia. However, it can cause gastrointestinal side effects, such as flatulence and diarrhea, due to the delayed carbohydrate absorption.

**✓ Correct Answer: A. Acarbose**